Cited by 372Cancer, Hypoxia, and MetabolismGlioma Diagnosis and TreatmentAmino Acid Enzymes and Metabolism

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance

Open access

Kim, Dohoon, Fiske, Brian P., Birsoy, Kivanc, Freinkman, Elizaveta, Kami, Kenjiro, Possemato, Richard L., Chudnovsky, Yakov, Pacold, Michael E., Chen, Walter W., Cantor, Jason R., Shelton, Laura M., Gui, Dan Y., Kwon, Manjae, Ramkissoon, Shakti H., Ligon, Keith L., Kang, Seong Woo, Snuderl, Matija, Vander Heiden, Matthew G., Sabatini, David M.·2015·Nature

DOI 10.1038/nature14363PMC PMC4533874

Open this paper in CoChat — free account

Abstract

Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment. Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. In human glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature14363

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Self-citation
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267

Show all 44 references

Sorted by citations

Items 101–200 of 372

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI
Hangel, G. J., Cadrien, C., Lazen, P., Furtner, J., Lipka, A., Niess, E., Hingerl, L., Motyka, S., Gruber, S., Strasser, B., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102433 · Cited by 69
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing
Parsa, S., Ortega-Molina, A., Ying, H., Jiang, M., Teater, M. R., Wang, J., Zhao, C., Reznik, E., Pasion, J. P., Kuo, D. C., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0080-0 · Cited by 66
Self-citation
Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness
Tiwari, V., Daoud, E. V., Hatanpaa, K. J., Gao, A., Zhang, S., An, Z., Ganji, S., Raisanen, J. M., Lewis, C. M., Askari, P., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa034 · Cited by 65
Advancing glioblastoma treatment by targeting metabolism
Zhao, J., Ma, X.-M., Gao, P., Han, X., Zhao, P., Xie, F., & Liu, M. (2024) · Neoplasia · doi:10.1016/j.neo.2024.100985 · Cited by 70
Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism
Meiser, J., Delcambre, S., Wegner, A., Jäger, C., Ghelfi, J., d’Hérouël, A. F., Dong, X., Weindl, D., Stautner, C., Nonnenmacher, Y., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.019 · Cited by 66
Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator β-glucan in a two-case ex vivo non-small-cell lung cancer studyPreprint
Fan, T. W. ‐., Warmoes, M. O., Sun, Q., Song, H., Turchan-Cholewo, J. T., Martin, J. T., Mahan, A. L., Higashi, R. M., & Lane, A. N. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000893 · Cited by 62
Glioma cells require one-carbon metabolism to survive glutamine starvation
Tanaka, K., Sasayama, T., Nagashima, H., Irino, Y., Takahashi, M., Izumi, Y., Uno, T., Satoh, N., Kitta, A., Kyotani, K., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01114-1 · Cited by 59
Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
Zeng, Y., Zhang, J., Xu, M., Chen, F., Zi, R., Yue, J., Zhang, Y., Chen, N., & Chin, Y. E. (2021) · Journal of Cancer · doi:10.7150/jca.60170 · Cited by 62
Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle
Sato, M., Kawana, K., Adachi, K., Fujimoto, A., Yoshida, M., Nakamura, H., Nishida, H., Inoue, T., Taguchi, A., Takahashi, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8947 · Cited by 63
Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways
Kahlert, U. D., Mooney, S. M., Natsumeda, M., Steiger, H., & Maciaczyk, J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30259 · Cited by 63
The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy
Chen, J., Na, R., Xiao, C. W., Wang, X., Wang, Y., Yan, D., Song, G., Liu, X., Chen, J., Lu, H., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01815-4 · Cited by 63
Cycling back to folate metabolism in cancer
Lee, Y., Vousden, K. H., & Hennequart, M. (2024) · Nature Cancer · doi:10.1038/s43018-024-00739-8 · Cited by 68
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Bernhard, C., Reita, D., Martin, S., Entz‐Werlé, N., & Dontenwill, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119137 · Cited by 66
The importance of mitochondrial folate enzymes in human colorectal cancer
Miyo, M., Konno, M., Colvin, H. S., Nishida, N., Koseki, J., Kawamoto, K., Tsunekuni, K., Nishimura, J., Hata, T., Takemasa, I., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5264 · Cited by 60
Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
Zhang, X., Chen, W., Fan, J., Wang, S., Xian, Z., Luan, J., Li, Y., Wang, Y., Nan, Y., Luo, M., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy041 · Cited by 60
Self-citation
Novel Pyrrolo[3,2- d ]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy
Dekhne, A. S., Shah, K., Ducker, G. S., Katinas, J. M., Wong-Roushar, J., Nayeen, M. J., Doshi, A., Ning, C., Bao, X., Frühauf, J., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0037 · Cited by 59
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight
Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57
Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells
Doshi, M. B., Lee, N., Tseyang, T., Ponomarova, O., Goel, H., Spears, M. E., Li, R., Zhu, L., Ashwood, C., Simin, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06676-3 · Cited by 42
Self-citation
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Kobayashi, Y., Kashima, H., Rahmanto, Y. S., Banno, K., Yu, Y., Matoba, Y., Watanabe, K., Iijima, M., Takeda, T., Kunitomi, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20046 · Cited by 57
Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy
Yu, Y., Yu, J., Ge, S., Su, Y., & Fan, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79928 · Cited by 60
Mice deficient in the Shmt2 gene have mitochondrial respiration defects and are embryonic lethal
Tani, H., Ohnishi, S., Shitara, H., Mito, T., Yamaguchi, M., Yonekawa, H., Hashizume, O., Ishikawa, K., Nakada, K., & Hayashi, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18828-3 · Cited by 54
Drug discovery inspired by bioactive small molecules from nature
Kim, S., Lim, S.-W., & Choi, J. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2157480 · Cited by 54
Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma
Zhuang, H., Wu, F., Wei, W., Dang, Y., Yang, B., Ma, X., Han, F., & Li, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1446-z · Cited by 56
Endogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 56
Self-citation
The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
Wang, J., Zhang, P., Zhong, J., Tan, M., Ge, J., Tao, L., Li, Y., Zhu, Y., Wu, L., Qiu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8382 · Cited by 55
Hypoxia-induced SHMT2 protein lactylation facilitates glycolysis and stemness of esophageal cancer cells
Qiao, Z., Li, Y., Li, S., Liu, S., & Cheng, Y. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04913-x · Cited by 52
Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures
Schwertz, G., Witschel, M. C., Rottmann, M., Bonnert, R. V., Leartsakulpanich, U., Chitnumsub, P., Jaruwat, A., Ittarat, W., Schäfer, A., Aponte, R. A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00008 · Cited by 52
A map of the altered glioma metabolism
Deshmukh, R. S., Allega, M. F., & Tardito, S. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.011 · Cited by 53
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Marrocco, I., Fabio Altieri, F., Rubini, E., Paglia, G., Chichiarelli, S., Giamogante, F., Macone, A., Perugia, G., Magliocca, F. M., Gurtner, A., et al. (2019) · Cells · doi:10.3390/cells8091048 · Cited by 51
Downregulation of glycine decarboxylase enhanced cofilin-mediated migration in hepatocellular carcinoma cells
Zhuang, H., Li, Q., Zhang, X., Ma, X., Wang, Z., Liu, Y., Yi, X., Chen, R., Han, F., Zhang, N., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.003 · Cited by 50
Rewiring of cortical glucose metabolism fuels human brain cancer growth
Scott, A. J., Mittal, A., Meghdadi, B., O’Brien, A. M., Bailleul, J., Palavalasa, S., Achreja, A., Zhou, W., Xu, J., Lin, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09460-7 · Cited by 58
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 52
Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation
Macpherson, J. A., Theisen, A., Masino, L., Fets, L., Driscoll, P. C., Encheva, V., Snijders, A. P., Martin, S. R., Kleinjung, J., Barran, P. E., et al. (2019) · eLife · doi:10.7554/elife.45068 · Cited by 50
The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling
Chen, R. Q., Xu, X., Liu, F., Li, C. Y., Li, Y. J., Li, X. R., Jiang, G., Hu, F., Liu, D., Pan, F., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01347 · Cited by 48
Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion
Koufaris, C., Gallage, S., Yang, T., Lau, C. E., Valbuena, G. N., & Keun, H. C. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00188 · Cited by 48
Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation
Liu, J., Hanavan, P. D., Kras, K. A., Ruiz, Y. W., Castle, E. P., Lake, D. F., Chen, X., O’Brien, D. R., Luo, H., Robertson, K. D., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00628 · Cited by 48
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells
Zhang, Y., Liu, Z., Wang, X., Jian, H., Xiao, H., & Wen, T. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00470-5 · Cited by 47
Linking Serine/Glycine Metabolism to Radiotherapy Resistance
Sánchez‐Castillo, A., Vooijs, M., & Kampen, K. R. (2021) · Cancers · doi:10.3390/cancers13061191 · Cited by 47
miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma
Wu, X., Deng, L., Tang, D., Ying, G., Yao, X., Liu, F., & Gui, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4506-8 · Cited by 47
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
Ning, S., Ma, S., Saleh, A. Q., Guo, L., Zhao, Z., & Chen, Y. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/4369253 · Cited by 47
Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
Yoshida, G. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00791 · Cited by 49
Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors
Qiu, R., Zhong, Y., Li, Q., Li, Y., & Fan, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.693215 · Cited by 49
MYCN and Metabolic Reprogramming in Neuroblastoma
Bansal, M., Gupta, A., & Ding, H. (2022) · Cancers · doi:10.3390/cancers14174113 · Cited by 46
Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses
Lee, S. E., Park, S., Yi, S., Choi, N. R., Lim, M. A., Chang, J. W., Won, H.-R., Kim, J. R., Ko, H. M., Chung, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45366-0 · Cited by 46
Give it or take it: the flux of one‐carbon in cancer cells
Meiser, J., & Vázquez, A. (2016) · FEBS Journal · doi:10.1111/febs.13731 · Cited by 47
Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow
Ser, Z., Gao, X., Johnson, C., Mehrmohamadi, M., Liu, X., Li, S., & Locasale, J. W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.035 · Cited by 46
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma
Wilke, A. C., Doebele, C., Zindel, A., Lee, K.-S., Rieke, S. A., Ceribelli, M., Comoglio, F., Phelan, J. D., Wang, J. Q., Pikman, Y., et al. (2021) · Blood · doi:10.1182/blood.2021012081 · Cited by 46
Research into cancer metabolomics: Towards a clinical metamorphosis
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45
‘Rod and ring’ formation from IMP dehydrogenase is regulated through the one-carbon metabolic pathway
Calise, S. J., Purich, D. L., Nguyen, T. M., Saleem, D. A., Krueger, C., Yin, J. D., & Chan, E. K. L. (2016) · Journal of Cell Science · doi:10.1242/jcs.183400 · Cited by 45
Protein interaction and functional data indicate MTHFD2 involvement in RNA processing and translation
Koufaris, C., & Nilsson, R. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0185-4 · Cited by 45
Integrated analysis of microfibrillar-associated proteins reveals MFAP4 as a novel biomarker in human cancers
Yang, J., Song, H., Chen, L., Cao, K., Zhang, Y., Li, Y., & Hao, X. (2018) · Epigenomics · doi:10.2217/epi-2018-0080 · Cited by 46
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Magnetic Resonance (MR) Metabolic Imaging in Glioma
Chaumeil, M. M., Lupo, J., & Ronen, S. M. (2015) · Brain Pathology · doi:10.1111/bpa.12310 · Cited by 44
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer
Matherly, L. H., Hou, Z., & Gangjee, A. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3473-8 · Cited by 44
Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression
Lu, C., Kang, T., Zhang, J., Yang, K., Liu, Y., Song, K., Lin, Q., Dixit, D., Gimple, R. C., Zhang, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58366-5 · Cited by 51
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
Zhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 44
MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK‐3β/β‐catenin signalling
Shi, Y., Xu, Y., Yao, J., Yan, C., Su, H., Zhang, X. Z., Chen, E., & Ying, K. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16715 · Cited by 43
Overexpression of SHMT2 predicts a poor prognosis and promotes tumor cell growth in bladder cancer
Zhang, P., & Yang, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.682856 · Cited by 41
Mass Spectrometry-Based Cellular Metabolomics: Current Approaches, Applications, and Future Directions
Domenick, T. M., Gill, E. L., Vedam‐Mai, V., & Yost, R. A. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04363 · Cited by 42
Cellular pharmacodynamics of a novel pyrrolo[3,2-d]pyrimidine inhibitor targeting mitochondrial and cytosolic one-carbon metabolism
Dekhne, A. S., Ning, C., Nayeen, M. J., Shah, K., Kalpage, H., Frühauf, J., Wallace-Povirk, A., O’Connor, C., Hou, Z., Kim, S., et al. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.117937 · Cited by 40
SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc
Qiao, Z., Li, Y., Cheng, Y., Li, S., & Liu, S. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01148-7 · Cited by 40
Subcellular one carbon metabolism in cancer, aging and epigenetics
Bernasocchi, T., & Mostoslavsky, R. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1451971 · Cited by 44
Glycine supplementation in vitro enhances porcine preimplantation embryo cell number and decreases apoptosis but does not lead to live births
Redel, B. K., Spate, L. D., Lee, K., Mao, J., Whitworth, K. M., & Prather, R. S. (2016) · Molecular Reproduction and Development · doi:10.1002/mrd.22618 · Cited by 40
Alterations in cellular metabolome after pharmacological inhibition of N otch in glioblastoma cells
Kahlert, U. D., Cheng, M., Koch, K., Marchionni, L., Fan, X., Raabe, E. H., Maciaczyk, J., Glunde, K., & Eberhart, C. G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29873 · Cited by 37
A Link between Deoxyribonucleotide Metabolites and Embryonic Cell-Cycle Control
Liu, B., Winkler, F., Herde, M., Witte, C., & Großhans, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.02.021 · Cited by 34
Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity
Alptekin, A., Ye, B., Yu, Y., Poole, C. J., van Riggelen, J., Zha, Y., & Ding, H. (2019) · Oncogene · doi:10.1038/s41388-019-0967-3 · Cited by 35
SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers
Usman, M., Hameed, Y., Ahmad, M., Iqbal, M. J., Maryam, A., Mazhar, A., Naz, S., Tanveer, R., Saeed, H., Bint-e-Fatima, et al. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220112142409 · Cited by 34
Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies
Locard‐Paulet, M., Palasca, O., & Jensen, L. J. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010604 · Cited by 34
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Wu, M., Wanggou, S., Li, X., Liu, Q., & Xie, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s130409 · Cited by 33
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martı́n-Castillo, B., Giardina, G., Joven, J., et al. (2021) · Cancers · doi:10.3390/cancers13164009 · Cited by 31
Developmental toxicity of glycine-coated silica nanoparticles in embryonic zebrafish
Dumitrescu, E., Karunaratne, D. P., Prochaska, M. K., Liu, X., Wallace, K. N., & Andreescu, S. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.06.016 · Cited by 33
An engineered photoswitchable mammalian pyruvate kinase
Gehrig, S. M., Macpherson, J. A., Driscoll, P. C., Symon, A., Martin, S. R., MacRae, J. I., Kleinjung, J., Fraternali, F., & Anastasiou, D. (2017) · FEBS Journal · doi:10.1111/febs.14175 · Cited by 33
Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme
Heiland, D. H., Gaebelein, A., Börries, M., Wörner, J., Pompe, N., Franco, P., Heynckes, S., Bartholomae, M., hAilín, D. Ó., Carro, M. S., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0680 · Cited by 34
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
Zhang, X., Wang, S., Nan, Y., Fan, J., Chen, W., Luan, J., Wang, Y., Liang, Y., Li, S., Tian, W., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9069-3 · Cited by 32
Self-citation
BRCA1-A and BRISC: multifunctional molecular machines for ubiquitin signaling
Rabl, J. (2020) · Biomolecules · doi:10.3390/biom10111503 · Cited by 31
Essential Function of the Serine Hydroxymethyl Transferase (SHMT) Gene During Rapid Syncytial Cell Cycles inDrosophila
Winkler, F., Kriebel, M., Clever, M., Gröning, S., & Großhans, J. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.043133 · Cited by 31
Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesis
Palaskas, N. J., Garcia, J. D., Shirazi, R., Shin, D. S., Puig-Saus, C., Braas, D., Ribas, A., & Graeber, T. G. (2019) · Cell Discovery · doi:10.1038/s41421-019-0130-x · Cited by 31
Serine hydroxymethyltransferase 2: a novel target for human cancer therapy
Xie, M., & Pei, D. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01144-z · Cited by 30
The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma
Yang, Y., Yuan, Y., Hu, W., Shang, Q.-X., & Chen, L.-Q. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1407440 · Cited by 30
SHMT2 Promotes Liver Regeneration Through Glycine-activated Akt/mTOR Pathway
Wang, M., Yuan, F., He, B., Zhang, J., Wu, H., Zheng, K., Zhang, W., Miao, M., & Gong, J. (2019) · Transplantation · doi:10.1097/tp.0000000000002747 · Cited by 29
Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control
Kang, P. J., Zheng, J., Lee, G., Son, D., Kim, I. Y., Song, G., Park, G., & You, S. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.02.003 · Cited by 29
Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer
Kujundžić, R. N., Stepanić, V., Milković, L., Gašparović, A. Č., Tomljanović, M., & Gall‐Tros̆elj, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051180 · Cited by 31
SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
Wang, W., Wang, M., Du, T., Hou, Z., You, S., Zhang, S., Ji, M., Xue, N., & Chen, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087150 · Cited by 29
Glycine cleavage system determines the fate of pluripotent stem cells via the regulation of senescence and epigenetic modifications
Tian, S., Feng, J., Cao, Y., Shen, S., Cai, Y., Yang, D., Yan, R., Wang, L., Zhang, H., Zhong, X., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900413 · Cited by 26
Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer
Berezowska, S., Galván, J. A., Langer, R., Bubendorf, L., Savic, S., Gugger, M., Schmid, R. A., & Marti, T. M. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-2057-z · Cited by 28
Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
Liao, Y., Wang, F., Zhang, Y., Cai, H., Song, F., & Hou, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01880-5 · Cited by 27
Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia
Swanson, M. A., Miller, K. R., Young, S. P., Tong, S., Ghaloul‐Gonzalez, L., Neira‐Fresneda, J., Schlichting, L., Peck, C. K., Gabel, L., Friederich, M. W., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12500 · Cited by 28
Identification of TWIST-interacting genes in prostate cancer
Lyu, P., Zhang, S., Yuen, H., McCrudden, C. M., Wen, Q., Chan, K., & Kwok, H. F. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0262-6 · Cited by 27
Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold
Schwertz, G., Witschel, M. C., Rottmann, M., Leartsakulpanich, U., Chitnumsub, P., Jaruwat, A., Amornwatcharapong, W., Ittarat, W., Schäfer, A., Aponte, R. A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800053 · Cited by 27
Phosphatase of regenerating liver‐3 regulates cancer cell metabolism in multiple myeloma
Abdollahi, P., Vandsemb, E. N., Elsaadi, S., Røst, L. M., Yang, R., Hjort, M. A., Andreassen, T., Misund, K., Slørdahl, T. S., Rø, T. B., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001920rr · Cited by 25
Branched-chain α-ketoacids aerobically activate HIF1α signalling in vascular cells
Xiao, W., Shrimali, N. M., Vigder, N., Oldham, W. M., Clish, C. B., He, H., Wong, S. J., Wertheim, B. M., Arons, E., Haigis, M. C., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01150-4 · Cited by 27
SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression
Cui, X., Cui, Y., Du, T., Jiang, X., Song, C. H., Zhang, S., Ma, C., Liu, Y., Ni, Q., Gao, Y., et al. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/3758697 · Cited by 25
Cancer proteome and metabolite changes linked to SHMT2
Tong, J., Krieger, J. R., Taylor, P., Bagshaw, R., Kang, J., Jeedigunta, S., Wybenga-Groot, L. E., Zhang, W., Badr, H., Mirhadi, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237981 · Cited by 24
Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification
Nguyen, T., Vemu, P. L., Hoy, G. E., Boudjadi, S., Chatterjee, B., Shern, J. F., Khan, J. I., Sun, W., & Barr, F. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138022 · Cited by 24
Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
Jin, X., Li, L., Peng, Q., Gan, C., Gao, L. P., He, S., Tan, S., Pu, W., Liu, Y., Gong, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104349 · Cited by 25
The Roles of SUMO in Metabolic Regulation
Kamynina, E., & Stover, P. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_9 · Cited by 25
Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKCβ2 Activation and Improving Mitochondrial Quality
Zhang, Y., Su, W., Zhang, Q., Xu, J., Liu, H., Luo, J., Zhan, L., Xia, Z., & Lei, S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9502895 · Cited by 24
Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
Luo, L., Zheng, Y., Lin, Z., Li, X., Li, X., Li, M., Cui, L., & Luo, H. (2021) · Journal of Immunology Research · doi:10.1155/2021/6647122 · Cited by 24
Connections between metabolism and epigenetic modifications in cancer
Wang, G., & Han, J. J. (2021) · Medical Review · doi:10.1515/mr-2021-0015 · Cited by 27

Authors: Kim, D., Fiske, B. P., Birsoy, K., Freinkman, E., Kami, K., Possemato, R. L., Chudnovsky, Y., Pacold, M. E., Chen, W. W., Cantor, J. R., Shelton, L. M., Gui, D. Y., Kwon, M., Ramkissoon, S. H., Ligon, K. L., Kang, S. W., Snuderl, M., Vander Heiden, M. G., & Sabatini, D. M.
Affiliations: Broad Institute (US)
Human Metabolome Technologies, Inc. (Japan) (JP)
Whitehead Institute for Biomedical Research (US)
Brigham and Women's Hospital (US)
NYU Langone Health (US)
Corresponding author: Sabatini, David M.
ORCID: Kim, Dohoon
Fiske, Brian P.
Possemato, Richard L.
Pacold, Michael E.
Chen, Walter W.
Cantor, Jason R.
Shelton, Laura M.
Gui, Dan Y.
Kwon, Manjae
Ligon, Keith L.
Snuderl, Matija
Sabatini, David M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2015-04
Volume: 520
Issue: 7547
Pages: 363-367
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature14363
PMC: PMC4533874
OpenAlex: W1993238514
Cited by: 368
References: 44
Citations by year: 2026: 25 · 2025: 22 · 2024: 21 · 2023: 28 · 2022: 41 · 2021: 42 · 2020: 25 · 2019: 39 · 2018: 34 · 2017: 30 · 2016: 42 · 2015: 18
FWCI: 13.77
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
RePEc: Research Papers in Economics (submittedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Radboud Repository (Radboud University) (submittedVersion)
PMC
Funders: Howard Hughes Medical Institute
National Cancer Institute (5-P30-CA14051, CA129105, K99CA168940, CA103866, R01CA103866, R01CA168653, R01CA129105, R00CA168940, P30CA014051)
National Institute of General Medical Sciences (T32GM007753, T32GM007287)
National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389, R37AI047389)
National Institute of Neurological Disorders and Stroke (K08NS087118)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords: SHMT2, glycine decarboxylase, glioblastoma, serine metabolism, glycine metabolism, oxygen consumption, PKM2, methylglyoxal, aminoacetone, tumor cell survival, tumor hypoxia
MeSH terms: Acetone, Animals, Brain Neoplasms, Cell Survival, Female, Glioblastoma, Glycine, Humans, Ischemia, Necrosis, Oxygen Consumption, Pyruvaldehyde, Pyruvate Kinase, Glycine Hydroxymethyltransferase, Cell Hypoxia, Xenograft Model Antitumor Assays, Cell Line, Tumor, Glycine Dehydrogenase (Decarboxylating), Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks